Pharmapedia Pro
Medicines/Generics/Ropinirole (HCl)

Ropinirole (HCl)

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Ropinirole (HCl) is a dopamine receptor agonist, used for the treatment of Parkinson`s disease. Ropinirole (HCl) is also used with levodopa in more advanced disease. It may also be used for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults.
Indications
Ropinirole (HCl) is primarily indicated in conditions like Idiopathic Parkinson's disease (PD) and Restless legs syndrome (RLS).
Contraindications
Ropinirole (HCl) is contraindicated in conditions like Hypersensitivity, Pregnancy, Lactation.
Side Effects
The severe or irreversible adverse effects of Ropinirole (HCl), which give rise to further complications include Hallucinations, Cardiac arrhythmias, Confusion, Anxiety, Psychosis, Depression, Postural hypotension, Amnesia. The signs and symptoms that are produced after the acute overdosage of Ropinirole (HCl) include Nausea, Vomiting, Confusion, Dizziness, Agitation, Orthostatic hypotension, Chest pain, Dystonia. The symptomatic adverse reactions produced by Ropinirole (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Abdominal pain, Confusion, Leg edema.
Warnings
Ropinirole should be used with caution in patients with mild to moderate hepatic impairment and renal impairment (avoid in severe); severe cardiovascular disease; major psychotic disorders; avoid abrupt withdrawal.
High Risk Groups
Drug should not be given to Pediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.25 mg (0.25 (0.25)) 8 hourly PO — Initial dose for 1st week. 0.5 mg (0.5 (0.5)) 8 hourly PO — Dose for 2nd week. 0.75 mg (0.75 (0.75)) 8 hourly PO — Dose for 3rd week. 1 mg (1 (1)) 8 hourly PO — Dose for 4th week. After week 4, if necessary, daily dosage may be increased by 1.5 mg/day on a weekly basis up to a dose of 9 mg/day, and then by up to 3 mg/day weekly to a total dose of 24 mg/day
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Ropinirole (HCl) was found.
Storage
Tab Store Below 25°C. Protect from Sunlight and Moisture.

Available Brands in Pakistan

3 active brands listed alphabetically.

REQUIP

Active

GLAXOSMITHKLINE

DML: REQUIP

Tabs

RONIROL

Active

HILTON PHARMA (PVT) LIMITED

DML: RONIROL

Tabs

ROPINOL

Active

AMARANT PHARMACEUTICALS (PVT)

DML: ROPINOL

Tabs

6 additional records are present but flagged "Unverified / Legacy" and not listed.